Healthcare Professionals
Please log in for special information and services
Vladimir Kosev Bulgaria

“Statement Vlado Statement Vlado Statement Vlado Statement Vlado .”Statement Vlado Statement Vlado Statement Vlado Statement Vlado"

Facts & Figures

AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.

Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Bulgarian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases. 

Bulgaria occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in XXXX. AOP Orphan Bulgaria is a Marketing & Sales, and Medical team for two therapeutic divisions.

 

420,000
people
PATIENTS WITH RARE DISEASES IN bulgaria
In Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases. In Bulgaria 420,000 people have been diagnosed with a rare disease.
available TREATMENTS
In Bulgaria AOP Orphan provides ten products. 
 
5
products
2
areas
two THERAPEUTIC AREAS
AOP Orphan Bulgaria covers two area of treatments: HematoOncology, as well as Neurology and Metabolic Disorders.

Vision & Mission

Milestones